Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Validity of cardiovascular risk prediction models in Latin America and among Hispanics in the United States of America: a systematic review.

Cortes-Bergoderi M, Thomas RJ, Albuquerque FN, Batsis JA, Burdiat G, Perez-Terzic C, Trejo-Gutierrez J, Lopez-Jimenez F.

Rev Panam Salud Publica. 2012 Aug;32(2):131-9. Review.

2.

Diabetes and cardiovascular disease. Is there a true Hispanic paradox?

Lerman-Garber I, Villa AR, Caballero E.

Rev Invest Clin. 2004 May-Jun;56(3):282-96. Review.

PMID:
15612509
3.
4.

Cardiovascular disease mortality in Hispanics and non-Hispanic whites.

Swenson CJ, Trepka MJ, Rewers MJ, Scarbro S, Hiatt WR, Hamman RF.

Am J Epidemiol. 2002 Nov 15;156(10):919-28.

PMID:
12419764
5.
6.

Avoiding the looming Latino/Hispanic cardiovascular health crisis: a call to action.

Davidson JA, Kannel WB, Lopez-Candales A, Morales L, Moreno PR, Ovalle F, Rodriguez CJ, Rodbard HW, Rosenson RS, Stern M.

Ethn Dis. 2007 Summer;17(3):568-73. Review.

PMID:
17985515
7.

Cardiovascular mortality in Hispanics compared to non-Hispanic whites: a systematic review and meta-analysis of the Hispanic paradox.

Cortes-Bergoderi M, Goel K, Murad MH, Allison T, Somers VK, Erwin PJ, Sochor O, Lopez-Jimenez F.

Eur J Intern Med. 2013 Dec;24(8):791-9. doi: 10.1016/j.ejim.2013.09.003. Epub 2013 Oct 2. Review.

PMID:
24095273
8.

[A comparison between the metabolic syndrome score and the Framingham risk score in the prediction of cardiovascular disease].

Yu H, Guo ZR, Hu XS, Zhou ZY, Wu M.

Zhonghua Liu Xing Bing Xue Za Zhi. 2010 Feb;31(2):208-12. Chinese.

PMID:
21215086
9.

Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group.

Newman AB, Spiekerman CF, Enright P, Lefkowitz D, Manolio T, Reynolds CF, Robbins J.

J Am Geriatr Soc. 2000 Feb;48(2):115-23.

PMID:
10682939
10.

Risk factors for cardiovascular and cerebrovascular death among African Americans and Hispanics in Los Angeles, California.

Henderson SO, Bretsky P, Henderson BE, Stram DO.

Acad Emerg Med. 2001 Dec;8(12):1163-72.

11.

Homocysteine and reclassification of cardiovascular disease risk.

Veeranna V, Zalawadiya SK, Niraj A, Pradhan J, Ference B, Burack RC, Jacob S, Afonso L.

J Am Coll Cardiol. 2011 Aug 30;58(10):1025-33. doi: 10.1016/j.jacc.2011.05.028.

12.

Kidney disease as a risk factor for recurrent cardiovascular disease and mortality.

Weiner DE, Tighiouart H, Stark PC, Amin MG, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ.

Am J Kidney Dis. 2004 Aug;44(2):198-206.

PMID:
15264177
13.

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.

Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR.

Circulation. 2004 Sep 7;110(10):1245-50. Epub 2004 Aug 23.

14.

Multicity study of air pollution and mortality in Latin America (the ESCALA study).

Romieu I, Gouveia N, Cifuentes LA, de Leon AP, Junger W, Vera J, Strappa V, Hurtado-Díaz M, Miranda-Soberanis V, Rojas-Bracho L, Carbajal-Arroyo L, Tzintzun-Cervantes G; HEI Health Review Committee..

Res Rep Health Eff Inst. 2012 Oct;(171):5-86.

PMID:
23311234
15.

Avoiding the looming Latino/Hispanic cardiovascular health crisis: a call to action.

Davidson JA, Kannel WB, Lopez-Candales A, Morales L, Moreno PR, Ovalle F, Rodriguez CJ, Rodbard HW, Rosenson RS, Stern M.

J Cardiometab Syndr. 2007 Fall;2(4):238-43. Review.

16.

Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data.

Bhopal R, Fischbacher C, Vartiainen E, Unwin N, White M, Alberti G.

J Public Health (Oxf). 2005 Mar;27(1):93-100.

PMID:
15749725
17.

Risk of cardiovascular events associated with positive serology for Chagas: a systematic review.

Linetzky B, Konfino J, Castellana N, De Maio F, Bahit MC, Orlandini A, Diaz R.

Int J Epidemiol. 2012 Oct;41(5):1356-66. doi: 10.1093/ije/dys125. Review.

PMID:
23045202
18.

Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.

Riddell T, Wells S, Jackson R, Lee AW, Crengle S, Bramley D, Ameratunga S, Pylypchuk R, Broad J, Marshall R, Kerr A.

N Z Med J. 2010 Feb 19;123(1309):50-61.

PMID:
20186242
19.

Cardiovascular risk prediction models for people with severe mental illness: results from the prediction and management of cardiovascular risk in people with severe mental illnesses (PRIMROSE) research program.

Osborn DP, Hardoon S, Omar RZ, Holt RI, King M, Larsen J, Marston L, Morris RW, Nazareth I, Walters K, Petersen I.

JAMA Psychiatry. 2015 Feb;72(2):143-51. doi: 10.1001/jamapsychiatry.2014.2133.

20.

Prognostic implications of surrogate markers of atherosclerosis in low to intermediate risk patients with type 2 diabetes.

Lau KK, Wong YK, Chan YH, Yiu KH, Teo KC, Li LS, Ho SL, Chan KH, Siu CW, Tse HF.

Cardiovasc Diabetol. 2012 Aug 18;11:101. doi: 10.1186/1475-2840-11-101.

Supplemental Content

Support Center